Advancements in Gastroenterology: A Weekly Review
Gastroenterologia
Advancements in Gastroenterology: A Weekly Review
This week's episode covers groundbreaking research in ulcerative colitis treatments, IBS management, peptic ulcer strategies, and MASH therapies, featuring insights from leading gastroenterology researchers.
Accedi o Registrati per ascoltare questo episodio
Bibliografia
1. Familial hypercholesterolaemia in children and adolescents: a European Atherosclerosis Society consensus statement.
Authors: Wiegman A, Bourbon M, Freiberger T, et al.
Journal: European heart journal, 2026 Jul 7
PMID: 42179051
DOI: 10.1093/eurheartj/ehag382
2. Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis.
Authors: Sandborn WJ, Baert F, Danese S, et al.
Journal: Gastroenterology, 2020 Feb
PMID: 31470005
DOI: 10.1053/j.gastro.2019.08.027
3. Chronic Pancreatitis.
Authors: Stram M, Liu S, Singhi AD
Journal: Surgical pathology clinics, 2016 Dec
PMID: 27926364
DOI: 10.1016/j.path.2016.05.008
4. Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
Authors: Sands BE, Sandborn WJ, Panaccione R, et al.
Journal: The New England journal of medicine, 2019 Sep 26
PMID: 31553833
DOI: 10.1056/NEJMoa1900750
5. Comparison of pharmacological therapies in metabolic dysfunction-associated steatohepatitis for fibrosis regression and MASH resolution: Systematic review and network meta-analysis.
Authors: Souza M, Al-Sharif L, Antunes VLJ, et al.
Journal: Hepatology (Baltimore, Md.), 2025 Dec 1
PMID: 39903735
DOI: 10.1097/HEP.0000000000001254
6. A Comprehensive Review on Ulcer and Their Treatment.
Authors: RaviKKumar VR, Rathi S, Singh S, et al.
Journal: Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology, 2023 Dec 21
PMID: 38755116
DOI: 10.62958/j.cjap.2023.006
7. Magnesium: Hype and Health Benefits.
Authors: Sankararaman S, Memel Z, Dubroff J, et al.
Journal: Current nutrition reports, 2026 Jul 22
PMID: 42484803
DOI: 10.1007/s13668-026-00786-w
8. Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis.
Authors: Goodoory VC, Khasawneh M, Black CJ, et al.
Journal: Gastroenterology, 2023 Nov
PMID: 37541528
DOI: 10.1053/j.gastro.2023.07.018
9. Rifaximin therapy for patients with irritable bowel syndrome without constipation.
Authors: Pimentel M, Lembo A, Chey WD, et al.
Journal: The New England journal of medicine, 2011 Jan 6
PMID: 21208106
DOI: 10.1056/NEJMoa1004409
Authors: Wiegman A, Bourbon M, Freiberger T, et al.
Journal: European heart journal, 2026 Jul 7
PMID: 42179051
DOI: 10.1093/eurheartj/ehag382
2. Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis.
Authors: Sandborn WJ, Baert F, Danese S, et al.
Journal: Gastroenterology, 2020 Feb
PMID: 31470005
DOI: 10.1053/j.gastro.2019.08.027
3. Chronic Pancreatitis.
Authors: Stram M, Liu S, Singhi AD
Journal: Surgical pathology clinics, 2016 Dec
PMID: 27926364
DOI: 10.1016/j.path.2016.05.008
4. Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
Authors: Sands BE, Sandborn WJ, Panaccione R, et al.
Journal: The New England journal of medicine, 2019 Sep 26
PMID: 31553833
DOI: 10.1056/NEJMoa1900750
5. Comparison of pharmacological therapies in metabolic dysfunction-associated steatohepatitis for fibrosis regression and MASH resolution: Systematic review and network meta-analysis.
Authors: Souza M, Al-Sharif L, Antunes VLJ, et al.
Journal: Hepatology (Baltimore, Md.), 2025 Dec 1
PMID: 39903735
DOI: 10.1097/HEP.0000000000001254
6. A Comprehensive Review on Ulcer and Their Treatment.
Authors: RaviKKumar VR, Rathi S, Singh S, et al.
Journal: Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology, 2023 Dec 21
PMID: 38755116
DOI: 10.62958/j.cjap.2023.006
7. Magnesium: Hype and Health Benefits.
Authors: Sankararaman S, Memel Z, Dubroff J, et al.
Journal: Current nutrition reports, 2026 Jul 22
PMID: 42484803
DOI: 10.1007/s13668-026-00786-w
8. Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis.
Authors: Goodoory VC, Khasawneh M, Black CJ, et al.
Journal: Gastroenterology, 2023 Nov
PMID: 37541528
DOI: 10.1053/j.gastro.2023.07.018
9. Rifaximin therapy for patients with irritable bowel syndrome without constipation.
Authors: Pimentel M, Lembo A, Chey WD, et al.
Journal: The New England journal of medicine, 2011 Jan 6
PMID: 21208106
DOI: 10.1056/NEJMoa1004409
